Meeting
2012 ASCO Annual Meeting
Which women with breast cancer do, and do not, undergo receptor status testing? A population-based study.
Authors
Linda Sharp
National Cancer Registry Ireland, Cork, Ireland
Linda Sharp , Marianna De Camargo Cancela , Harry Comber
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Health Services Research
Track
Health Services Research
Sub Track
Disparities/Health Equity
Citation
J Clin Oncol 30, 2012 (suppl; abstr 6036)
DOI
10.1200/jco.2012.30.15_suppl.6036
Abstract #
6036
Poster Bd #
24
Abstract Disclosures
Similar Posters
Poster
2015 Breast Cancer Symposium
Predictors of chemotherapy-induced peripheral neuropathy among breast cancer patients treated with taxanes.
First Author: Nellowe Candelario
Poster
2023 ASCO Annual Meeting
Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer.
First Author: Esther G Chong
Poster
2021 ASCO Annual Meeting
Survival time in urban center breast cancer patients with CNS metastasis with or without visceral metastasis.
First Author: Miriam Pearl Klahr
Poster
2017 ASCO Annual Meeting
Prognostic significance of tumor subtypes in women with breast cancer according to stage: A population-based study.
First Author: Jose Pablo Leone